AAAAAA

   
Results: 1-11 |
Results: 11
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
Authors: Ambrose, PG Grasela, DM Grasela, TH Passarell, J Mayer, HB Pierce, PF
Citation: Pg. Ambrose et al., Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections, ANTIM AG CH, 45(10), 2001, pp. 2793-2797
Clinical pharmacology of gatifloxacin, a new fluoroquinolone
Authors: Grasela, DM
Citation: Dm. Grasela, Clinical pharmacology of gatifloxacin, a new fluoroquinolone, CLIN INF D, 31, 2000, pp. S51-S58
The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae
Authors: Ambrose, PG Grasela, DM
Citation: Pg. Ambrose et Dm. Grasela, The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae, DIAG MICR I, 38(3), 2000, pp. 151-157
Pharmacokinetics of gatifloxacin: Dosing considerations and use in specialpopulations - Introduction
Authors: Grasela, DM
Citation: Dm. Grasela, Pharmacokinetics of gatifloxacin: Dosing considerations and use in specialpopulations - Introduction, PHARMACOTHE, 20(6), 2000, pp. 47S-48S
A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men
Authors: Gajjar, DA LaCreta, FP Uderman, HD Kollia, GD Duncan, G Birkhofer, MJ Grasela, DM
Citation: Da. Gajjar et al., A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men, PHARMACOTHE, 20(6), 2000, pp. 49S-58S
Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults
Authors: LaCreta, FP Kaul, S Kollia, GD Duncan, G Randall, DM Grasela, DM
Citation: Fp. Lacreta et al., Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults, PHARMACOTHE, 20(6), 2000, pp. 59S-66S
Age and gender effects on the pharmacokinetics of gatifloxacin
Authors: LaCreta, FP Kollia, GD Duncan, G Behr, D Grasela, DM
Citation: Fp. Lacreta et al., Age and gender effects on the pharmacokinetics of gatifloxacin, PHARMACOTHE, 20(6), 2000, pp. 67S-75S
Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise
Authors: Gajjar, DA LaCreta, FP Kollia, GD Stolz, RR Berger, S Smith, WB Swingle, M Grasela, DM
Citation: Da. Gajjar et al., Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise, PHARMACOTHE, 20(6), 2000, pp. 76S-86S
Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment
Authors: Grasela, DM Christofalo, B Kollia, GD Duncan, G Noveck, R Manning, JA LaCreta, FP
Citation: Dm. Grasela et al., Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment, PHARMACOTHE, 20(6), 2000, pp. 87S-94S
Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers
Authors: Grasela, DM LaCreta, FP Kollia, GD Randall, DM Uderman, HD
Citation: Dm. Grasela et al., Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers, PHARMACOTHE, 20(3), 2000, pp. 330-335
Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis
Authors: Grasela, DM Stoltz, RR Barry, M Bone, M Mangold, B O'Grady, P Raymond, R Haworth, SJ
Citation: Dm. Grasela et al., Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis, ANTIM AG CH, 44(8), 2000, pp. 2149-2153
Risultati: 1-11 |